Rheumatoid arthritis develops when the immune system mistakenly attacks the lining of the joints, but no single factor flips that switch. It results from a combination of genetic susceptibility, environmental exposures, hormonal shifts, and microbial triggers that collectively push the immune system toward self-attack. The disease affects roughly 0.5 to 1% of the global population, with women diagnosed two to three times more often than men.
Genetics Set the Stage
Your genes don’t guarantee you’ll develop rheumatoid arthritis, but they heavily influence whether your immune system is prone to it. The strongest genetic link involves a group of immune system genes that help your body distinguish its own tissue from foreign invaders. Specific variations in these genes, collectively called the “shared epitope,” appear in 64 to 82% of people with rheumatoid arthritis, compared with 39 to 52% of healthy individuals. Certain high-risk gene combinations can raise the odds dramatically, with one pairing increasing risk by as much as 28-fold.
These genetic variants are especially tied to a specific form of the disease where the body produces antibodies against its own modified proteins (called anti-citrullinated protein antibodies, or ACPA). In people who test positive for these antibodies, the shared epitope explains about 18% of the genetic risk. In those who test negative, it accounts for only about 2.4%, suggesting different subtypes of RA may have partly different genetic roots.
Family history matters in practical terms. Having a first-degree relative with rheumatoid arthritis, a parent or sibling, increases your risk by roughly three to five times compared with the general population. The closer the family relationship, the higher the risk.
Smoking Is the Strongest Environmental Trigger
Of all the environmental factors studied, cigarette smoking has the most consistent and well-documented link to rheumatoid arthritis. Smoking appears to damage proteins in the lungs by chemically altering them, converting a building block called arginine into a different form called citrulline. This process, known as citrullination, creates modified proteins that the immune system may no longer recognize as “self.” In genetically susceptible people, the body then produces antibodies against these altered proteins, setting up the autoimmune response that eventually targets the joints.
Smoking also triggers inflammatory signaling molecules in synovial fluid, the liquid that cushions your joints. Hydrocarbons in tobacco smoke provoke an inflammatory response that is most pronounced in joint tissue, which helps explain why a habit affecting the lungs ends up damaging the knees, hands, and wrists. People who smoke and carry the high-risk gene variants face a compounded risk that is far greater than either factor alone.
Hormones Help Explain the Gender Gap
The fact that women develop rheumatoid arthritis two to three times more often than men points to sex hormones as a contributing factor. Estrogen and progesterone appear to have a protective effect at higher levels. During pregnancy, when both hormones surge, many women with existing RA experience a noticeable improvement in symptoms. The reverse is also true: the postpartum period, when hormone levels drop sharply, is a well-known window for new RA onset or flares.
Menopause represents another vulnerable period. As estrogen and progesterone decline permanently, the risk and severity of rheumatoid arthritis tend to increase. This pattern is consistent across studies, though researchers still lack detailed human data showing exactly how these hormonal shifts alter the immune pathways involved.
Gum Disease and a Specific Oral Bacterium
One of the more surprising connections in RA research involves a bacterium commonly found in the mouths of people with periodontal (gum) disease. This organism, Porphyromonas gingivalis, produces its own version of the enzyme that citrullinates proteins, the same chemical modification triggered by smoking. When this bacterium infects gum tissue, it can citrullinate both its own surface proteins and human proteins, potentially breaking the immune system’s tolerance and triggering antibody production against the body’s own tissues.
Research published in PLOS Pathogens demonstrated that P. gingivalis significantly increased levels of autoantibodies against both collagen (a key joint protein) and citrullinated proteins in animal models. When the gene responsible for the bacterium’s citrullinating enzyme was deleted, the heightened immune response disappeared. This strongly suggests the enzyme itself, not just the infection, is the mechanistic link between gum disease and joint inflammation.
The Gut Microbiome in Early Disease
The bacteria living in your intestines also play a role. People with new-onset rheumatoid arthritis show a distinct shift in their gut bacterial populations compared to healthy individuals. One species, Prevotella copri, is significantly over-represented in the stool of people with early RA. This expansion comes at the expense of other beneficial bacteria that help regulate immune tolerance, effectively tilting the gut environment toward inflammation.
The connection goes beyond simple correlation. In 42% of patients with new-onset RA, immune cells in the blood responded to a specific protein from P. copri by mounting an inflammatory response. A subset of both new-onset and chronic RA patients also produced antibodies against this bacterium, and those antibody levels correlated with inflammatory immune cell activity and the presence of the same anti-citrullinated protein antibodies that define the most common form of RA. Dysbiosis, the term for an unbalanced microbial community, has also been observed in the mouth and salivary glands of RA patients, not just the gut.
Obesity and Chronic Low-Grade Inflammation
Carrying excess weight increases the risk of rheumatoid arthritis, and the mechanism involves more than just mechanical stress on joints. Fat tissue is metabolically active, producing signaling molecules called adipokines that regulate inflammation throughout the body. In obesity, the balance between pro-inflammatory and anti-inflammatory adipokines shifts toward a chronically inflamed state.
Research from two large cohorts found that higher levels of one adipokine, adiponectin, were associated with increased RA risk specifically in people who were overweight or obese, with a 17% increased risk per unit increase. This association was not present in people of normal weight, suggesting that the chronic inflammatory background of obesity is necessary to expose the link. In other words, obesity may not directly cause RA, but it creates an inflammatory environment where other risk factors become more potent.
What Happens Inside the Joint
Understanding the triggers is one part of the picture. The other is understanding what actually goes wrong once the immune system turns on the joints. The core problem is a runaway inflammatory cascade in the synovium, the thin membrane lining each joint. Immune cells flood the synovium and release inflammatory signaling molecules that recruit still more immune cells, creating a self-sustaining cycle.
One of the most important of these signals promotes inflammation in several ways simultaneously. It drives immune B cells to mature into antibody-producing factories, fueling the autoimmune response. It pushes T cells to develop into a particularly inflammatory subtype. It recruits bone-dissolving cells called osteoclasts, which is why RA can erode bone over time. It stimulates the growth of new blood vessels in the joint lining, feeding a thickened, aggressive tissue called pannus that invades and destroys cartilage. It also inhibits the production of proteoglycans, the molecules that give cartilage its cushioning properties, directly contributing to cartilage breakdown.
Over time, this inflammatory process shifts from acute to chronic. The immune cells infiltrating the joint transition from short-lived first responders to longer-lived cells that sustain damage over months and years. This is why early treatment matters: once the chronic inflammatory loop is established, it becomes harder to interrupt.
How These Factors Work Together
No single cause is sufficient on its own. The current understanding is a multi-hit model. Genetic susceptibility loads the gun. Environmental exposures like smoking, gum disease, or gut dysbiosis pull the trigger by generating citrullinated proteins that the immune system reacts against. Hormonal shifts and obesity amplify the inflammatory response. The result is a perfect storm where the immune system begins producing antibodies against the body’s own modified proteins, those antibodies accumulate in joint tissue, and a destructive inflammatory cycle takes hold.
This also explains why the disease can appear to strike without an obvious cause. Someone may carry genetic risk variants for decades without symptoms, until a combination of hormonal changes, a shift in gut bacteria, or a period of weight gain tips the balance. ACPA antibodies can be detected in the blood years before joint symptoms appear, suggesting the autoimmune process begins long before anyone notices pain or swelling.